default author photo

Weijin Huang

Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines

WHO Collaborating Center for Standardization and Evaluation of Biologicals

China

SCHOLARLY PAPERS

7

DOWNLOADS

345

TOTAL CITATIONS

9

Scholarly Papers (7)

1.

Increase in Antibody Titers from H5n1 Vaccine Confers Cross-Protection Against Highly Pathogenic H5N1 Influenza Virus

Number of pages: 13 Posted: 26 Nov 2024
Government of the People's Republic of China - National Institutes for Food and Drug Control, Sinovac Biotech CO., Ltd., Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Sinovac Biotech CO., Ltd., Government of the People's Republic of China - National Institutes for Food and Drug Control and Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines
Downloads 102 (684,672)

Abstract:

Loading...

highly pathogenic avian influenza, H5N1, vaccine, pseudovirus, neutralization assay

2.

The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity

Number of pages: 36 Posted: 14 Jul 2020
WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Tsinghua University - Center for Global Health and Infectious Diseases, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Tsinghua University - Center for Global Health and Infectious Diseases, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines and WHO Collaborating Center for Standardization and Evaluation of Biologicals
Downloads 68 (899,324)
Citation 9

Abstract:

Loading...

SARS-CoV-2, COVID-19, mutation, glycosylation, neutralizing antibody, immune escape

3.

A Dual-View Deep Learning-Driven Discovery of Cinnamoyl Anthranilic Acid Derivatives Against Orthopoxvirus Through Targeting Host Itgb3

Number of pages: 34 Posted: 29 Jan 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, China Agricultural University, Northeast Normal University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Institute of Medicinal Biotechnology, Northeast Normal University, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - CAMS Key Laboratory of Antiviral Drug Research
Downloads 54 (1,041,696)

Abstract:

Loading...

dual-view deep learning, anti-orthopoxvirus, target identification, integrin beta 3, photoaffinity probe

4.

No Higher Infectivity But Immune Escape of SARS-CoV-2 501Y.V2 Variants

Number of pages: 37 Posted: 29 Jan 2021
WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Beijing Biocytogen Co., Ltd., Sino Biological Inc. - Beijing Antibody Research Key Laboratory, Tsinghua University - Center for Global Health and Infectious Diseases, University of South China - Translational Medicine Institute, Chinese Center for Disease Control and Prevention (China CDC) - National Institute for Viral Disease Control and Prevention, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines and WHO Collaborating Center for Standardization and Evaluation of Biologicals
Downloads 52 (1,052,702)

Abstract:

Loading...

5.

Hyperglycemia Promotes Cathepsin L Maturation and Enhances Diabetic Complications: Implications for SARS-CoV-2 Infection

Number of pages: 47 Posted: 26 Jul 2023
Capital Medical University - Department of Endocrinology, Capital Medical University - Department of Endocrinology, Capital Medical University - Department of Endocrinology, Capital Medical University - Department of Endocrinology, Capital Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Department of Science and Technology, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Capital Medical University - Department of Endocrinology and Capital Medical University - Department of Endocrinology
Downloads 32 (1,399,036)

Abstract:

Loading...

Diabetes, Cathepsin L, COVID-19

6.

Antigenic Analysis of the Influenza B Virus Hemagglutinin Protein

Number of pages: 38 Posted: 30 Nov 2023
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, National Vaccine and Serum Institute, Government of the People's Republic of China - National Institutes for Food and Drug Control, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) and Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines
Downloads 25 (1,399,036)

Abstract:

Loading...

Influenza B virus, antigenicity, vaccine strains, pseudotyped viruses

7.

The pan-filovirus activity of an IGF2-fused monoclonal antibody is impaired by cross-engagement with IGF1R which is improved by introducing Y27L mutation in IGF2

Number of pages: 45 Posted: 04 Apr 2026
Academy of Military Medical Sciences, Jiangsu University of Science and Technology, Henan University, Academy of Military Medical Sciences, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Academy of Military Medical Sciences, Academy of Military Medical Sciences, Institute of Pharmacology and Toxicology - State Key Laboratory of Toxicology and Medical Countermeasures, Academy of Military Medical Sciences, Academy of Military Medical Sciences, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Academy of Military Medical Sciences, Institute of Pharmacology and Toxicology - State Key Laboratory of Toxicology and Medical Countermeasures and Jiangsu University of Science and Technology
Downloads 12 (1,571,455)

Abstract:

Loading...

Filoviruses, Neutralizing antibody, IGF1R, IGF2R